Raia Drogasil S.A

RADL3•SA

Healthcare Brazil Pharmaceutical Retailers

Need professional-grade analysis? Visit stockanalysis.com

R$22.48

-3.77%

End of day

Market Cap

$42.69B

P/E Ratio

30.71

Employees

73,895

Dividend Yield

1.26%

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	—	-3.21	-0.36	3.01	0.67	0.02	0.42
Calmar	—	-6.13	-0.46	3.64	0.47	0.01	0.17
Sharpe	—	-3.30	-0.25	1.94	0.44	0.01	0.14
Omega	—	0.24	0.98	1.33	1.12	1.03	1.03
Martin	—	-11.05	-1.23	12.92	0.91	0.02	1.61
Ulcer	—	7.51	6.19	4.71	21.14	21.68	14.03

Raia Drogasil S.A (RADL3) Price Performance

Raia Drogasil S.A (RADL3) trades on SA in BRL. The company is classified in the Healthcare sector under the Pharmaceutical Retailers industry. The stock currently trades at BRL22.48, down 3.77% from the previous close.

Over the past year, RADL3 has traded between a low of BRL12.95 and a high of BRL27.00. The stock has gained 22.3% over this period. It is currently 16.7% below its 52-week high.

Raia Drogasil S.A has a market capitalization of $42.69B, with a price-to-earnings ratio of 30.71 and a dividend yield of 1.26%.

About Raia Drogasil S.A

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil.

Company Info

Sector: Healthcare
Industry: Pharmaceutical Retailers
Exchange: SA
Currency: BRL
Country: Brazil

Financial Metrics

Revenue (TTM): $44.25B
EBITDA: $3.52B
Profit Margin: 2.93%
EPS (TTM): 0.78
Book Value: 4.19

Technical Indicators

52 Week High: R$27.42
52 Week Low: N/A
50 Day MA: R$25.03
200 Day MA: R$19.83
Beta: 0.16

Valuation

Trailing P/E: 30.71
Forward P/E: 24.21
Price/Sales: 0.96
Price/Book: 5.78
Enterprise Value: $50.62B